Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Baminercept in Moderate to Severe Ulcerative Colitis
2010-019558-42Phase 2Completed
- Sponsor
- Biogen
- Start
- Oct 2010
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in autoimmune colitis comparing Baminercept with Placebo (2 arms). Primary endpoint: Clinical response at Week 12. Started Oct 2010; status: completed.
02
Drugs
baminercept
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2010-019558-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019558-42.